BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24445298)

  • 1. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: BBN as an urothelial carcinogen.
    Vasconcelos-Nóbrega C; Colaço A; Lopes C; Oliveira PA
    In Vivo; 2012; 26(4):727-39. PubMed ID: 22773588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
    Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
    Dahm HH; von der Haar C; Rübben H
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
    de Oliveira ML; Souza Rocha N; Fukushima S; de Camargo JL
    Teratog Carcinog Mutagen; 1995; 15(4):191-9. PubMed ID: 8838633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
    Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
    Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BBN-driven urinary bladder cancer mouse model.
    Korac-Prlic J; Degoricija M; Vilović K; Vujević S; Terzić J
    Methods Cell Biol; 2021; 163():77-92. PubMed ID: 33785170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
    Dunois-Lardé C; Levrel O; Brams A; Thiery JP; Radvanyi F
    Mol Carcinog; 2005 Mar; 42(3):142-9. PubMed ID: 15690367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic credentialing of murine carcinogen-induced urothelial cancer.
    Afify H; Ghoneum A; Almousa S; Abdulfattah AY; Warren B; Langsten K; Gonzalez D; Casals R; Bharadwaj M; Kridel S; Said N
    Sci Rep; 2021 Nov; 11(1):22085. PubMed ID: 34764423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose dependency of γ-H2AX formation in the rat urinary bladder treated with genotoxic and nongenotoxic bladder carcinogens.
    Yamada T; Toyoda T; Matsushita K; Morikawa T; Ogawa K
    J Appl Toxicol; 2020 Sep; 40(9):1219-1227. PubMed ID: 32203627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
    Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.
    Hicks RM; James C; Webbe G
    Br J Cancer; 1980 Nov; 42(5):730-55. PubMed ID: 7459210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
    Chuang JJ; Dai YC; Lin YL; Chen YY; Lin WH; Chan HL; Liu YW
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):322-330. PubMed ID: 24998975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.